APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antimalarial Medication

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antimalarial Medication Industry Growth and Trends Forecast to 2032

20 December 202598 pages

Choose your research edition.

Industry ResearchAntimalarial Medication Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimalarial Medication Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Antimalarial Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimalarial Medication Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimalarial Medication Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Antimalarial Medication market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antimalarial Medication is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antimalarial Medication is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antimalarial Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antimalarial Medication include Sun Pharmaceutical Industries, Novartis, Merck, Pfizer, GlaxoSmithKline and F. Hoffmann-La Roche, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antimalarial Medication market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antimalarial Medication market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antimalarial Medication market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antimalarial Medication.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antimalarial Medication market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antimalarial Medication Market by Company

Sun Pharmaceutical Industries

Novartis

Merck

Pfizer

GlaxoSmithKline

F. Hoffmann-La Roche

Antimalarial Medication Segment by Type

Plasmodium Malariae

Plasmodium Ovale

Plasmodium Vivax

Plasmodium Falciparum

Antimalarial Medication Segment by Application

E- Commerce

Retail Pharmacy

Hospital Pharmacy

Others

Antimalarial Medication Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimalarial Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimalarial Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimalarial Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antimalarial Medication manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antimalarial Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Plasmodium Malariae Table 2. Major Company of Plasmodium Ovale Table 3. Major Company of Plasmodium Vivax Table 4. Major Company of Plasmodium Falciparum Table 5. Global Antimalarial Medication Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 7. Global Antimalarial Medication Sales Market Share in Volume by Type (2021-2026) Table 8. Global Antimalarial Medication Sales by Type (2021-2026) & (US$ Million) Table 9. Global Antimalarial Medication Sales Market Share in Value by Type (2021-2026) Table 10. Global Antimalarial Medication Price by Type (2021-2026) & (US$/Unit) Table 11. Global Antimalarial Medication Sales by Type (2027-2032) & (K Units) Table 12. Global Antimalarial Medication Sales Market Share in Volume by Type (2027-2032) Table 13. Global Antimalarial Medication Sales by Type (2027-2032) & (US$ Million) Table 14. Global Antimalarial Medication Sales Market Share in Value by Type (2027-2032) Table 15. Global Antimalarial Medication Price by Type (2027-2032) & (US$/Unit) Table 16. North America Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 17. North America Antimalarial Medication Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 19. Europe Antimalarial Medication Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Antimalarial Medication Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 23. Latin America Antimalarial Medication Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Antimalarial Medication Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Antimalarial Medication Sales by Type (2021-2026) & (US$ Million) Table 26. Antimalarial Medication Industry Trends Table 27. Antimalarial Medication Industry Drivers Table 28. Antimalarial Medication Industry Opportunities and Challenges Table 29. Antimalarial Medication Industry Restraints Table 30. Global Antimalarial Medication Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Antimalarial Medication Revenue Market Share by Company (2021-2026) Table 32. Global Antimalarial Medication Sales by Company (2021-2026) & (K Units) Table 33. Global Antimalarial Medication Sales Share by Company (2021-2026) Table 34. Global Antimalarial Medication Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Antimalarial Medication Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Antimalarial Medication Major Company Production Sites and Headquarters Table 37. Global Antimalarial Medication Company, Product Type & Application Table 38. Global Antimalarial Medication Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Antimalarial Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Antimalarial Medication Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Antimalarial Medication Sales by Region (2021-2026) & (K Units) Table 43. Global Antimalarial Medication Sales Market Share in Volume by Region (2021-2026) Table 44. Global Antimalarial Medication Sales by Region (2021-2026) & (US$ Million) Table 45. Global Antimalarial Medication Sales Market Share in Value by Region (2021-2026) Table 46. Global Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Antimalarial Medication Sales by Region (2027-2032) & (K Units) Table 48. Global Antimalarial Medication Sales Market Share in Volume by Region (2027-2032) Table 49. Global Antimalarial Medication Sales by Region (2027-2032) & (US$ Million) Table 50. Global Antimalarial Medication Sales Market Share in Value by Region (2027-2032) Table 51. Global Antimalarial Medication Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Antimalarial Medication Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 54. Global Antimalarial Medication Sales Market Share in Volume by Application (2021-2026) Table 55. Global Antimalarial Medication Sales by Application (2021-2026) & (US$ Million) Table 56. Global Antimalarial Medication Sales Market Share in Value by Application (2021-2026) Table 57. Global Antimalarial Medication Price by Application (2021-2026) & (US$/Unit) Table 58. Global Antimalarial Medication Sales by Application (2027-2032) & (K Units) Table 59. Global Antimalarial Medication Sales Market Share in Volume by Application (2027-2032) Table 60. Global Antimalarial Medication Sales by Application (2027-2032) & (US$ Million) Table 61. Global Antimalarial Medication Sales Market Share in Value by Application (2027-2032) Table 62. Global Antimalarial Medication Price by Application (2027-2032) & (US$/Unit) Table 63. North America Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 64. North America Antimalarial Medication Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 66. Europe Antimalarial Medication Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Antimalarial Medication Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 70. Latin America Antimalarial Medication Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Antimalarial Medication Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Antimalarial Medication Sales by Application (2021-2026) & (US$ Million) Table 73. Sun Pharmaceutical Industries Company Information Table 74. Sun Pharmaceutical Industries Business Overview Table 75. Sun Pharmaceutical Industries Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio Table 77. Sun Pharmaceutical Industries Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Novartis Antimalarial Medication Product Portfolio Table 82. Novartis Recent Development Table 83. Merck Company Information Table 84. Merck Business Overview Table 85. Merck Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Merck Antimalarial Medication Product Portfolio Table 87. Merck Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Pfizer Antimalarial Medication Product Portfolio Table 92. Pfizer Recent Development Table 93. GlaxoSmithKline Company Information Table 94. GlaxoSmithKline Business Overview Table 95. GlaxoSmithKline Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. GlaxoSmithKline Antimalarial Medication Product Portfolio Table 97. GlaxoSmithKline Recent Development Table 98. F. Hoffmann-La Roche Company Information Table 99. F. Hoffmann-La Roche Business Overview Table 100. F. Hoffmann-La Roche Antimalarial Medication Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. F. Hoffmann-La Roche Antimalarial Medication Product Portfolio Table 102. F. Hoffmann-La Roche Recent Development Table 103. North America Antimalarial Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 104. North America Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 105. North America Antimalarial Medication Sales Market Share by Country (2021-2026) Table 106. North America Antimalarial Medication Sales Forecast by Country (2027-2032) & (K Units) Table 107. North America Antimalarial Medication Sales Market Share Forecast by Country (2027-2032) Table 108. North America Antimalarial Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. North America Antimalarial Medication Market Size by Country (2021-2026) & (US$ Million) Table 110. North America Antimalarial Medication Market Share by Country (2021-2026) Table 111. North America Antimalarial Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. North America Antimalarial Medication Market Share Forecast by Country (2027-2032) Table 113. Europe Antimalarial Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 114. Europe Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 115. Europe Antimalarial Medication Sales Market Share by Country (2021-2026) Table 116. Europe Antimalarial Medication Sales Forecast by Country (2027-2032) & (K Units) Table 117. Europe Antimalarial Medication Sales Market Share Forecast by Country (2027-2032) Table 118. Europe Antimalarial Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Antimalarial Medication Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Antimalarial Medication Market Share by Country (2021-2026) Table 121. Europe Antimalarial Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Antimalarial Medication Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Antimalarial Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 125. Asia-Pacific Antimalarial Medication Sales Market Share by Country (2021-2026) Table 126. Asia-Pacific Antimalarial Medication Sales Forecast by Country (2027-2032) & (K Units) Table 127. Asia-Pacific Antimalarial Medication Sales Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Antimalarial Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Antimalarial Medication Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Antimalarial Medication Market Share by Country (2021-2026) Table 131. Asia-Pacific Antimalarial Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Antimalarial Medication Market Share Forecast by Country (2027-2032) Table 133. Latin America Antimalarial Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Latin America Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 135. Latin America Antimalarial Medication Sales Market Share by Country (2021-2026) Table 136. Latin America Antimalarial Medication Sales Forecast by Country (2027-2032) & (K Units) Table 137. Latin America Antimalarial Medication Sales Market Share Forecast by Country (2027-2032) Table 138. Latin America Antimalarial Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Latin America Antimalarial Medication Market Size by Country (2021-2026) & (US$ Million) Table 140. Latin America Antimalarial Medication Market Share by Country (2021-2026) Table 141. Latin America Antimalarial Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Latin America Antimalarial Medication Market Share Forecast by Country (2027-2032) Table 143. Middle East and Africa Antimalarial Medication Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Middle East and Africa Antimalarial Medication Sales by Country (2021-2026) & (K Units) Table 145. Middle East and Africa Antimalarial Medication Sales Market Share by Country (2021-2026) Table 146. Middle East and Africa Antimalarial Medication Sales Forecast by Country (2027-2032) & (K Units) Table 147. Middle East and Africa Antimalarial Medication Sales Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa Antimalarial Medication Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa Antimalarial Medication Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East and Africa Antimalarial Medication Market Share by Country (2021-2026) Table 151. Middle East and Africa Antimalarial Medication Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East and Africa Antimalarial Medication Market Share Forecast by Country (2027-2032) Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Antimalarial Medication Distributors List Table 156. Antimalarial Medication Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Antimalarial Medication Image Figure 2. Global Antimalarial Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimalarial Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Antimalarial Medication Sales (2021-2032) & (K Units) Figure 5. Plasmodium Malariae Image Figure 6. Global Plasmodium Malariae Sales YoY Growth (2021-2032) & (K Units) Figure 7. Plasmodium Ovale Image Figure 8. Global Plasmodium Ovale Sales YoY Growth (2021-2032) & (K Units) Figure 9. Plasmodium Vivax Image Figure 10. Global Plasmodium Vivax Sales YoY Growth (2021-2032) & (K Units) Figure 11. Plasmodium Falciparum Image Figure 12. Global Plasmodium Falciparum Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Antimalarial Medication Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Antimalarial Medication Market Share by Type 2025 VS 2032 Figure 15. North America Antimalarial Medication Sales Market Share in Volume by Type in 2025 Figure 16. North America Antimalarial Medication Sales Market Share in Value by Type in 2025 Figure 17. Europe Antimalarial Medication Sales Market Share in Volume by Type in 2025 Figure 18. Europe Antimalarial Medication Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Antimalarial Medication Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Antimalarial Medication Sales Market Share in Value by Type in 2025 Figure 21. Latin America Antimalarial Medication Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Antimalarial Medication Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Antimalarial Medication Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Antimalarial Medication Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Antimalarial Medication Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. E- Commerce Image Figure 28. Global E- Commerce Sales YoY Growth (2021-2032) & (K Units) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Pharmacy Image Figure 32. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Antimalarial Medication Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Antimalarial Medication Market Share by Application 2025 VS 2032 Figure 37. North America Antimalarial Medication Sales Market Share in Volume by Application in 2025 Figure 38. North America Antimalarial Medication Sales Market Share in Value by Application in 2025 Figure 39. Europe Antimalarial Medication Sales Market Share in Volume by Application in 2025 Figure 40. Europe Antimalarial Medication Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Antimalarial Medication Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Antimalarial Medication Sales Market Share in Value by Application in 2025 Figure 43. Latin America Antimalarial Medication Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Antimalarial Medication Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Antimalarial Medication Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Antimalarial Medication Sales Market Share in Value by Application in 2025 Figure 47. North America Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Antimalarial Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Antimalarial Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Antimalarial Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Antimalarial Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Antimalarial Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Antimalarial Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Antimalarial Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Antimalarial Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Antimalarial Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Antimalarial Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Antimalarial Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Antimalarial Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Antimalarial Medication Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Antimalarial Medication Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Antimalarial Medication Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Antimalarial Medication Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Antimalarial Medication Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Antimalarial Medication Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmodium Malariae
  • Plasmodium Ovale
  • Plasmodium Vivax
  • Plasmodium Falciparum
Applications
  • E- Commerce
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Sun Pharmaceutical Industries
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • F. Hoffmann-La Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antimalarial Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antimalarial Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antimalarial Medication Market by Type
  6. 1.3.1 Plasmodium Malariae
  7. 1.3.2 Plasmodium Ovale
  8. 1.3.3 Plasmodium Vivax
  9. 1.3.4 Plasmodium Falciparum
  10. 1.4 Global Antimalarial Medication Market Size by Type
  11. 1.4.1 Global Antimalarial Medication Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Antimalarial Medication Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Antimalarial Medication Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Antimalarial Medication Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Antimalarial Medication Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Antimalarial Medication Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Antimalarial Medication Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Antimalarial Medication Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antimalarial Medication Industry Trends
  2. 2.2 Antimalarial Medication Industry Drivers
  3. 2.3 Antimalarial Medication Industry Opportunities and Challenges
  4. 2.4 Antimalarial Medication Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antimalarial Medication Revenue (2021-2026)
  2. 3.2 Global Top Players by Antimalarial Medication Sales (2021-2026)
  3. 3.3 Global Top Players by Antimalarial Medication Price (2021-2026)
  4. 3.4 Global Antimalarial Medication Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antimalarial Medication Major Company Production Sites & Headquarters
  6. 3.6 Global Antimalarial Medication Company, Product Type & Application
  7. 3.7 Global Antimalarial Medication Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antimalarial Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antimalarial Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antimalarial Medication Tier 1, Tier 2, and Tier 3
4 Antimalarial Medication Regional Status and Outlook
  1. 4.1 Global Antimalarial Medication Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antimalarial Medication Historic Market Size by Region
  3. 4.2.1 Global Antimalarial Medication Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antimalarial Medication Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antimalarial Medication Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antimalarial Medication Forecasted Market Size by Region
  7. 4.3.1 Global Antimalarial Medication Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antimalarial Medication Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antimalarial Medication Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antimalarial Medication by Application
  1. 5.1 Antimalarial Medication Market by Application
  2. 5.1.1 E- Commerce
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Antimalarial Medication Market Size by Application
  7. 5.2.1 Global Antimalarial Medication Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antimalarial Medication Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antimalarial Medication Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antimalarial Medication Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antimalarial Medication Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antimalarial Medication Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antimalarial Medication Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antimalarial Medication Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sun Pharmaceutical Industries
  2. 6.1.1 Sun Pharmaceutical Industries Company Information
  3. 6.1.2 Sun Pharmaceutical Industries Business Overview
  4. 6.1.3 Sun Pharmaceutical Industries Antimalarial Medication Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sun Pharmaceutical Industries Antimalarial Medication Product Portfolio
  6. 6.1.5 Sun Pharmaceutical Industries Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Antimalarial Medication Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Antimalarial Medication Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Antimalarial Medication Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Antimalarial Medication Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Antimalarial Medication Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Antimalarial Medication Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Antimalarial Medication Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Antimalarial Medication Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 F. Hoffmann-La Roche
  32. 6.6.1 F. Hoffmann-La Roche Company Information
  33. 6.6.2 F. Hoffmann-La Roche Business Overview
  34. 6.6.3 F. Hoffmann-La Roche Antimalarial Medication Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 F. Hoffmann-La Roche Antimalarial Medication Product Portfolio
  36. 6.6.5 F. Hoffmann-La Roche Recent Developments
7 North America by Country
  1. 7.1 North America Antimalarial Medication Sales by Country
  2. 7.1.1 North America Antimalarial Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antimalarial Medication Sales by Country (2021-2026)
  4. 7.1.3 North America Antimalarial Medication Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antimalarial Medication Market Size by Country
  6. 7.2.1 North America Antimalarial Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antimalarial Medication Market Size by Country (2021-2026)
  8. 7.2.3 North America Antimalarial Medication Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antimalarial Medication Sales by Country
  2. 8.1.1 Europe Antimalarial Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antimalarial Medication Sales by Country (2021-2026)
  4. 8.1.3 Europe Antimalarial Medication Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antimalarial Medication Market Size by Country
  6. 8.2.1 Europe Antimalarial Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antimalarial Medication Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antimalarial Medication Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antimalarial Medication Sales by Country
  2. 9.1.1 Asia-Pacific Antimalarial Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antimalarial Medication Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antimalarial Medication Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antimalarial Medication Market Size by Country
  6. 9.2.1 Asia-Pacific Antimalarial Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antimalarial Medication Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antimalarial Medication Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antimalarial Medication Sales by Country
  2. 10.1.1 South America Antimalarial Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antimalarial Medication Sales by Country (2021-2026)
  4. 10.1.3 South America Antimalarial Medication Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antimalarial Medication Market Size by Country
  6. 10.2.1 South America Antimalarial Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antimalarial Medication Market Size by Country (2021-2026)
  8. 10.2.3 South America Antimalarial Medication Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antimalarial Medication Sales by Country
  2. 11.1.1 Middle East and Africa Antimalarial Medication Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antimalarial Medication Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antimalarial Medication Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antimalarial Medication Market Size by Country
  6. 11.2.1 Middle East and Africa Antimalarial Medication Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antimalarial Medication Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antimalarial Medication Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antimalarial Medication Value Chain Analysis
  2. 12.1.1 Antimalarial Medication Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antimalarial Medication Production Mode & Process
  7. 12.2 Antimalarial Medication Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antimalarial Medication Distributors
  10. 12.2.3 Antimalarial Medication Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst